Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer
Abroad (travel likely)RecruitingPHASE1
Conditions
Localized Muscle Invasive Bladder Urothelial Carcinoma · Muscle-Invasive Bladder Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Contact: Study coordinator (Shila Gupta, MD)
Study leads
Shilpa Gupta, MD
Principal Investigator
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center